throbber
Differentiation of mononuclear precursors into osteoclasts
`on the surface of Si-substituted hydroxyapatite
`
`C.M. Botelho,1,2 R.A. Brooks,3 G. Spence,3 I. McFarlane,4 M.A. Lopes,1,2 S.M. Best,5 J.D. Santos,1,2
`N. Rushton,3 W. Bonfield5
`1INEB - Instituto de Engenharia Biome´dica, Laborato´rio de Biomateriais, Rua do Campo Alegre, 823,
`4150 –180 Porto, Portugal
`2FEUP - Faculdade de Engenharia da Universidade do Porto, DEMM, Rua Dr. Roberto Frias,
`4200 – 465 Porto, Portugal
`3Orthopaedic Research Unit, Box 180, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QQ, United Kingdom
`4Clinical Biochemistry, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 2QQ, United Kingdom
`5Department of Materials Science and Metallurgy, University of Cambridge, Cambridge CB2 3QZ, United Kingdom
`
`Received 26 August 2005; revised 28 December 2005; accepted 10 January 2006
`Published online 31 May 2006 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/jbm.a.30726
`
`In healthy bone, resorption and synthesis are in
`Abstract:
`perfect coordination. In previous studies we demonstrated
`that the incorporation of silicon into the hydroxyapatite
`(HA) lattice enhances the proliferation and differentiation of
`human osteoblasts. Therefore, the aim of this study was to
`demonstrate the effect of silicon-substituted HA (0.8 and 1.5
`wt % Si-HA) on the differentiation of mononuclear cells into
`osteoclasts, using two different starting cultures, peripheral
`blood mononuclear cells (PBMC) and monocytes expressing
`the CD14 antigen (CD14⫹). Through this study, it was pos-
`sible to demonstrate that Si-HA allows the differentiation of
`mononuclear cells into mature osteoclasts, independent of
`the starting culture, PBMC or CD14⫹. Most of the cells on
`the surface of the materials expressed osteoclastic markers:
`actin rings, several nuclei, positivity for tartrate-resistant
`
`acid phosphatase (TRAP), and vitronectin receptor. In the
`presence of osteoclasts, a higher release of calcium and
`phosphate into the medium from the 1.5 wt % Si-HA sub-
`strate was detected when compared to the HA substrate;
`therefore, these results indicate higher osteoclastic resorp-
`tive activity on the 1.5 wt % Si-HA surface. Si-HA can be
`resorbed by cellular mechanisms and have a stimulatory
`effect on osteoclasts, although the underlying mechanism is
`still poorly understood. © 2006 Wiley Periodicals, Inc.
`J Biomed Mater Res 78A: 709–720, 2006
`
`Key words: peripheral blood mononuclear cells; monocytes
`CD14 positive; differentiation; osteoclasts; silicon-substi-
`tuted hydroxyapatite
`
`INTRODUCTION
`
`The ideal bone graft for many applications would be
`a material that can both be resorbed and induce bone
`formation, and thereby being completely replaced by
`new bone. Bone is a dynamic organ because of its
`constant remodeling. This process can be divided into
`two main steps: resorption, where the “old” bone is
`resorbed by the osteoclasts, and synthesis, where the
`osteoblasts lay down new layers of bone.1
`In healthy bone, resorption and synthesis are in
`perfect coordination. Disruption to the balance be-
`
`tween resorption and formation can lead to osteopo-
`rosis, which is characterized by the loss of bone mass,2
`and osteopetrosis, resulting from a failure of oste-
`oclasts to resorb bone.3 The osteoclast is the only cell
`capable of resorbing mature bone. It is a tissue-specific
`macrophage polykaryon created by the differentiation
`and fusion of monocyte/macrophage precursor cells.4
`The resorption takes place under the ruffled border,
`where protons and proteases are secreted, leading to
`the formation of resorption lacunae.4
`In the last decade, there has been a breakthrough in
`the understanding of osteoclastogenesis, because of
`the discovery of the receptor activator of nuclear factor
`␬␤ligand (RANKL) in 1998. It was identified as an
`osteoblast-producing ligand, which promotes oste-
`oclast differentiation.4,5 RANK is a type I transmem-
`brane receptor of the TNF receptor superfamily that
`was identified in a dendritic cell cDNA library.6 Sev-
`eral studies showed that it is possible to generate
`MILLENIUM EXHIBIT 2050
`(cid:20)(cid:3)(cid:82)(cid:73)(cid:3)(cid:20)(cid:21)
`Baxter Healthcare Corp. et al. v. Millenium Biologix, LLC
`IPR2013-00582, -00590
`
`Correspondence to: R.A. Brooks; email: rb10003@cam.ac.uk
`Contract grant sponsor: Fundac¸a˜o para a Cieˆncia e Tecno-
`logia (FCT); contract grant numbers: SFRH/BD/6173 and
`POCTI/CTM/49238/2002
`
`© 2006 Wiley Periodicals, Inc.
`
`

`

`710
`
`BOTELHO ET AL.
`
`MATERIALS AND METHODS
`
`HA and Si-HA were prepared by a chemical precipitation
`route; the protocol is fully described elsewhere.16 –18 Sin-
`tered powders of the HA and Si-HA materials were pre-
`pared by compacting the as-precipitated powders and sin-
`tering it at 1300°C. The samples were sterilized by heat
`(180°C) for a period of 2 h.
`Two different osteoclast precursor cell populations were
`used: PBMC and CD14 positive monocytes (CD14⫹), as de-
`scribed later.
`
`resorbed by cellular mechanisms under physiologic
`conditions.13
`In previous studies, we demonstrated that the incor-
`poration of silicon into the HA lattice increases osteo-
`blast proliferation and differentiation,14 and Gibson et al.
`reported that the presence of this ion increases the met-
`abolic activity of osteoblast-like cells in vitro.15 Patel et al.
`showed an increase in bone apposition/ingrowth re-
`lated to the concentration of silicon incorporated into the
`HA lattice, although no osteoclast-like cells were ob-
`served on the surface or proximity of this material.13 The
`aim of this study was to assess the effect of silicon
`incorporation into HA on the differentiation of mononu-
`clear cells into mature osteoclasts, using two different
`precursor populations, PBMC and monocytes express-
`ing CD14, and to determine whether this material can be
`resorbed by osteoclasts.
`
`osteoclasts in vitro from peripheral mononuclear blood
`cells (PBMC), using RANKL and macrophage colony
`stimulating factor (MCSF), a polypeptide growth fac-
`tor.7,8 Quinn et al. suggested that osteoclasts are de-
`rived from monocytes that expressed the macrophage-
`associated antigen CD14 (CD14⫹).8 These results were
`supported by Massey et al., who showed that CD14⫹
`cells from PBMC showed enhanced osteoclastic bone
`resorption in co-cultures with UMR 106 rat osteoblast-
`like cells.9 The use of co-culture is related to the ability
`of osteoblast/stromal cells to produce the two hema-
`topoietic
`factors needed for osteoclastogenesis,
`RANKL and MCSF.4
`The use of soluble RANKL and MCSF allows the
`formation of mature osteoclasts in vitro directly from
`osteoclast precursors, eliminating the need for a co-
`culture system (PBMC and UMRS 106 rat osteoblast-
`like cells). The major advantage of this method is that
`only one cell type is used, and the final osteoclast
`culture is free of osteosarcoma cells.5 RANKL and
`MCSF induce gene expression for tartrate-resistant
`acid phosphatase (TRAP), cathepsin K, calcitonin re-
`␤
`ceptor, and ␣
`3-integrin (vitronectin receptor) that
`v
`are characteristic of mature osteoclasts.4 Therefore, in
`vitro osteoclasts can be identified by TRAP staining (a
`characteristic shared with macrophages), multinucle-
`arity, formation of an actin ring structure, a polar cell
`␤
`body during resorption, and by the presence of av
`3
`integrin.5,10 This integrin belongs to the superfamily of
`adhesion proteins, named as “vitronectin receptor,”
`because it binds to the extracellular matrix protein
`␤
`vitronectin.10 In osteoclasts, av
`3 is the predominant
`integrin, quantitatively and functionally, and it can
`mediate the recognition of several RGD-motif contain-
`ing bone-matrix proteins.10
`The PBMCs were isolated from a buffy coat, obtained
`Biomaterials are designed to fulfill a purpose; in the
`from the blood of healthy donors. Buffy coat cells were
`case of bone regeneration, they should stimulate the
`diluted in phosphate buffer solution (PBS) and transferred to
`proliferation and differentiation of osteoblast cells,
`tubes containing Histopaque-1077® (Sigma-Aldrich, Poole,
`UK), which allows the separation of erythrocytes, neutro-
`leading to the formation of “new bone.” They should
`phils, platelets, and PBMC by density, and the protocol is
`also be resorbed by a cellular mechanism to keep the
`fully described elsewhere.19 The end product is a mix cul-
`normal balance between bone formation and resorp-
`ture of monocytes, platelets, and lymphocytes.
`tion. It has been shown that it is possible to assess the
`The cells were suspended in ␣-MEM medium, with 10%
`resorbability of biomaterial by cellular mechanisms in
`(v/v) human AB serum, 1% (v/v) glutamine, and 30 ␮g/mL
`vitro.1,11,12 Schiling et al. reported that poly(methyl
`vitamin C (attachment medium). They were seeded at a
`methacrylate) cannot be resorbed by osteoclasts as no
`concentration of 2 ⫻ 106 cells/mL and allowed to attach for
`resorption pits were visualized, although these fea-
`2 h at 37°C, in a 5% CO2 atmosphere. After this period, the
`non-adherent cells were removed by washing and 250 ␮L of
`tures were present on the surface of calcium phos-
`attachment medium containing 25 ng/mL of MCSF and 30
`phate materials, indicating its resorbability by oste-
`ng/mL of RANKL was added. Experimental samples will be
`oclasts.1 Doi et al. reported that the incorporation of
`referred to as HA OC: 0.8 wt % Si-HA OC and 1.5 wt %
`carbonate ions increased osteoclast resorption in
`Si-HA OC. After 2 h of attachment, a set of samples (n ⫽ 3,
`vitro.11 Patel et al. reported similar results in vivo; in
`for each material) was stained with toluidine blue to visu-
`this case, the incorporation of carbonate ions into the
`alize the nucleus. The cells were visualized using a light
`hydroxyapatite (HA) lattice increased the number of
`microscope.
`multinucleated phagocytic cells
`resembling oste-
`The medium was changed every 3 days for a period of 21
`oclasts in close proximity to or directly on the surface
`days and analyzed for calcium (Ca2⫹) and phosphate
`3⫺) using automated colorimetric assays, calcium and
`of carbonate HA, indicating that this material was
`(PO4
`(cid:21)(cid:3)(cid:82)(cid:73)(cid:3)(cid:20)(cid:21)
`
`Peripheral blood mononuclear cells
`
`Journal of Biomedical Materials Research Part A DOI 10.1002/jbm.a
`
`

`

`DIFFERENTIATION OF MONONUCLEAR PRECURSORS INTO OSTEOCLASTS
`
`711
`
`RESULTS
`
`Peripheral blood mononuclear cells
`
`(Dade Behring, Deerfield,
`phosphorous flex® reagents,
`USA) on a Dimension RxL Integrated Chemistry System.
`Two different controls were used: (a) the samples without
`cells were incubated only in attachment medium (referred to
`as HA, 0.8 wt % Si-HA and 1.5 wt % Si-HA) and (b) the
`samples were incubated with 2 ⫻ 106 cells/mL of PBMC, but
`only in attachment medium, without cytokines (designated
`as HA PBMC; 0.8 wt % Si-HA and 1.5 wt % Si-HA PBMC).
`Following 21 days of culture, the medium was removed,
`and the samples were washed with phosphate buffered
`saline solution, after which the cells were fixed for 5 min in
`4% paraformaldehyde and stained for TRAP.20 The sub-
`strate was naphthol AS-BI phosphate (Sigma-Aldrich, Poole,
`UK). Tartrate resistance was assessed in the presence of
`0.05M sodium tartrate.
`
`CD14ⴙ
`
`After 2 h of incubation, mononuclear cells attached
`at the surface of all materials. The cells attached to the
`surface of Si-HA seemed to form clusters (Fig. 1).
`On the HA surface, the cells were sparser than on
`Si-HA (Fig. 2). Although the difference in adherent
`cells between the materials did not reach statistical
`significance,
`these results support previous ones
`where a similar trend was observed regarding the
`adhesion of human osteoblasts; 0.8 wt % Si-HA
`promoted greater adhesion and proliferation of human
`osteoblasts compared to HA.14 Further research showed
`that 0.8 wt % Si-HA not only shows higher osteoblast
`adhesion when compared to HA but also when com-
`pared to 1.5 wt % Si-HA (data not shown).
`After a period of 21 days, the culture was terminated.
`The cells on the surface of the three materials showed
`typical features of osteoclasts, they were multinucleated
`(white arrow) and TRAP positive (Fig. 3).
`The release of calcium and phosphate into the me-
`dium was measured in three experimental conditions,
`to evaluate the resorptive ability of osteoclasts.
`The calcium release from HA to the medium was
`similar in all the three experimental conditions [Fig.
`4(a)]: HA in attachment medium, HA PBMC, and HA
`OC. Although a slight increase in the phosphate con-
`centrations was observed from the samples containing
`osteoclasts at day 19 [Fig. 4(b)], it was not statistically
`significant and, furthermore, the trend of phosphate
`release between the controls and the experimental
`samples is exactly the same. Therefore, it is not possi-
`ble to conclude that the slight increase in phosphate
`release is due to osteoclast activity.
`The behavior of the osteoclasts on the 0.8 wt %
`Si-HA surface differs from HA. In this case, at day 19,
`a slight increase in the calcium content of the medium
`with osteoclasts was detected, although it did not
`reach statistical significance [Fig. 5(a)]. While the in-
`crease in phosphate at day 19 reached statistical sig-
`nificance when compared to the values observed with
`the controls (0.8 wt % Si-HA – 1.10 mmol/L, p ⬍ 0.007;
`0.8 wt % Si-HA PBMC – 1.11 mmol/L, p ⬍ 0.045; and
`0.8 wt % Si-HA OC – 1.42 mmol/L) [Fig. 5(b)]. This
`could indicate that the osteoclasts observed on the
`surface of 0.8 wt % Si-HA are active and resorbing.
`The calcium concentration of the medium from the
`experimental sample 1.5 wt % Si-HA OC at day 19 was
`significantly higher when compared to the control
`samples [Fig. 6(a)] (1.5 wt % Si-HA – 1.88 mmol/L, p ⬍
`0.002; 1.5 wt % Si-HA PBMC – 1.89 mmol/L, p ⬍ 0.003;
`and 1.5 wt % Si-HA OC – 2.39 mmol/L). A similar
`All results were statistically evaluated by ANOVA, and
`result was observed for phosphate [Fig. 6(b)] (1.5 wt %
`posthoc testing used Bonferroni’s correction on SPSS statisti-
`Si-HA – 1.10 mmol/L, p ⬍ 0.001; 1.5 wt % Si-HA
`cal software. Significance was set at the 5% level, (p ⬍ 0.05).
`(cid:22)(cid:3)(cid:82)(cid:73)(cid:3)(cid:20)(cid:21)
`
`The first step to obtain a pure culture of CD14⫹ cells was
`the same as described earlier, but with the addition of a
`magnetic separation step. After centrifugation with His-
`topaque, the cells were labeled with magnetic microbeads®,
`presenting anti-CD14 antibodies and placed in a magnetic
`column (Miltenyi Biotec, Bisley, UK), where the CD14⫹ cells
`were retained by the column. Following removal of the
`magnetic source, the column was washed with a Macs Buff-
`er® (Miltenyi Biotec) and the CD14⫹ cells were collected.
`The cells were seeded at 2 ⫻ 106 cells/mL and incubated for
`a period of 2 h in an attachment medium at 37°C in a 5% CO2
`atmosphere. After this period, the non-adherent cells were
`washed off and 250 ␮L of attachment medium containing 25
`ng/mL of MCSF and 30 ng/mL of RANKL was added for a
`period of 21 days, (the experimental samples will be referred
`to as HA OC: 0.8 and 1.5 wt % Si-HA OC). Two different
`controls were used: (a) the cells were seeded at 2 ⫻ 106
`cells/mL with attachment medium but no cytokines were
`added (referred to as HA NC; 0.8 and 1.5 wt % Si-HA NC),
`(b) the cells were also seeded at 2 ⫻ 106 cells/mL with
`attachment medium plus 25 ng/mL of MCSF (samples des-
`ignated as HA MCSF; 0.8 and 1.5 wt % Si-HA MCSF).
`The medium was changed every 7 days for a period of 21
`calcium (Ca2⫹)
`days
`and analyzed for
`and phos-
`3⫺) using a colorimetric assay, as described ear-
`phate (PO4
`lier.
`After 21 days, the cells were fixed in 4% paraformalde-
`hyde/phosphate buffered saline solution, pH 7.4, at room
`temperature for 15 min. Using immunocytochemistry, the
`cells were stained with Phalloidin FITC (1 ␮g/mL), which
`binds to F-actin. The vitronectin receptor was identified
`␤
`using a primary mouse antibody against av
`3, and a second-
`ary antibody conjugated to TRITC to demonstrate vitronec-
`tin receptors (681 ␮g/mL). The nuclei were stained using
`4⬘,6-diamidino-2-phenylindole (20 ␮g/mL). The fluorescent
`stains were visualized using fluorescence microscopy (FM)
`and confocal laser scanning microscopy (CLSM).
`
`Statistical analysis
`
`Journal of Biomedical Materials Research Part A DOI 10.1002/jbm.a
`
`

`

`712
`
`BOTELHO ET AL.
`
`When comparing the samples with osteoclasts from
`the three materials at day 19, the increase in calcium
`and phosphate concentrations of the medium is asso-
`ciated with the increase in the silicon content of the
`sample. A statistical difference between HA and 1.5 wt
`% Si-HA (calcium p ⬍ 0.007; phosphate p ⬍ 0.001) was
`detected, although no statistically significant differ-
`ence was observed between 0.8 wt % Si-HA and HA or
`between the two compositions of Si-HA.
`
`CD14ⴙ
`
`A similar analysis protocol was followed with the
`CD14⫹ cultures, although in this case the osteoclast
`markers, actin rings, and vitronectin receptor were
`assessed in addition to TRAP staining and measure-
`ment of the calcium and phosphate release.
`After 21 days, most of the cells present at the surface
`the three materials were TRAP positive and
`of
`multinucleated. The localization of actin distribution
`using FITC-labeled phalloidin demonstrated the char-
`acteristic actin ring on the surface of HA and Si-HA.
`Very few cells differentiated on the control surfaces (NC
`or MCSF) or formed actin rings, as can be seen in the FM
`images (Fig. 7). On the other hand, most of the cells on
`the surface of the experimental samples presented actin
`rings, although some of them had discontinuities. They
`were positive for vitronectin (Fig. 8), and several nuclei
`were observed inside the actin ring [Fig. 8(d)].
`Similar results were obtained for Si-HA; the cells
`were multinucleated, presented actin rings, most of
`them complete, and they also presented podosomes
`rich in vitronectin. The cells were also positive for vitro-
`nectin and were multinucleated. On both compositions a
`large number of osteoclasts were present (Fig. 9).
`As mentioned earlier, osteoclasts are actively mi-
`grating cells, and they can form microfilaments called
`
`Figure 1. Distribution of adherent PBMC on (a) HA; (b) 0.8
`wt % Si-HA; and (c) 1.5 wt % Si-HA after 2 h of incubation. (i)
`The platelets and (ii) the nucleus of mononuclear cells were
`stained with toluidine blue. [Color figure can be viewed in the
`online issue, which is available at www.interscience.wiley.
`com.]
`
`PBMC – 1.11 mmol/L, p ⬍ 0.001; and 1.5 wt % Si-HA
`OC – 1.42 mmol/L). Once again this result could
`Figure 2. Number of adherent PBMC/mm2 after 2 h of
`indicate that the osteoclasts are active and resorbing.
`incubation.
`(cid:23)(cid:3)(cid:82)(cid:73)(cid:3)(cid:20)(cid:21)
`
`Journal of Biomedical Materials Research Part A DOI 10.1002/jbm.a
`
`

`

`DIFFERENTIATION OF MONONUCLEAR PRECURSORS INTO OSTEOCLASTS
`
`713
`
`Figure 4. Calcium (a) and phosphate (b) concentration of
`the medium at different time points for the HA controls and
`the HA with osteoclasts (n ⫽ 3).
`
`Figure 3. Multinucleated, TRAP-positive cells on the sur-
`face of (a) HA; (b) 0.8 wt % Si-HA; and (c) 1.5 wt % Si-HA
`after 21 days of incubation. White arrow, nuclei. [Color
`figure can be viewed in the online issue, which is available
`at www.interscience.wiley.com.]
`
`Figure 5. Calcium (a) and phosphate (b) concentration of
`podosomes, which are rich in vitronectin receptor
`the medium at different time points for the 0.8 wt % Si-HA
`(␣
`␤
`3). The accumulation of these structures precedes
`controls and the 0.8 wt % Si-HA samples with osteoclasts.
`v
`(*Statistical difference p ⬍ 0.05, n ⫽ 3).
`the resorption phase. Podosomes were visible in more
`(cid:24)(cid:3)(cid:82)(cid:73)(cid:3)(cid:20)(cid:21)
`
`Journal of Biomedical Materials Research Part A DOI 10.1002/jbm.a
`
`

`

`714
`
`BOTELHO ET AL.
`
`Figure 6. Calcium (a) and phosphate (b) concentration in
`the medium at different time points for the 1.5 wt % Si-HA
`controls and the 1.5 wt % Si-HA sample with osteoclasts.
`(*Statistical difference p ⬍ 0.05, n ⫽ 3).
`
`detail by CLSM (Fig. 10). This fact could indicate that
`the osteoclasts are entering the resorption phase. It can
`be seen in the CLSM images that some cells on the
`surface on Si-HA formed podosomes [Fig. 10(c,d), white
`arrows]. The localization of the microfilaments showing
`the actin ring is very important, because they reflect the
`osteoclast phases of migration and resorption.
`The results obtained regarding calcium and phos-
`phate release were similar to those described previ-
`ously for PBMCs. Calcium and phosphate concentra-
`tions were analyzed at every medium change, until
`the final day of culture.
`In this case, earlier phosphate release into the me-
`dium of HA OC was observed, as soon as day 8 [Fig.
`11(a)]. At day 21, a slight increase in phosphate con-
`centration in the medium containing osteoclasts was
`noted. A similar trend was observed for calcium (HA
`NC – 1.88 mmol/L; HA MCSF – 1.88 mmol/L; and
`HA OC – 1.97 mmol/L) [Fig. 11(b)]. However, none of
`these results reached a statistically significant differ-
`ence.
`A higher concentration of phosphate was observed
`at day 8, 15, and 21 from the samples containing 0.8 wt
`% Si-HA OC, but when compared to the controls these
`were not statistically significant [Fig. 12(a)]. Once
`again, a higher release of calcium was observed by the
`(cid:25)(cid:3)(cid:82)(cid:73)(cid:3)(cid:20)(cid:21)
`
`Figure 7. Fluorescence microscopy showing few cells with
`actin rings (white arrow). (a) HA MCSF; (b) 0.8 wt % Si-HA
`MCSF; (c) 1.5 wt % Si-HA MCSF, after 21 days of incubation.
`[Color figure can be viewed in the online issue, which is
`available at www.interscience.wiley.com.]
`
`Journal of Biomedical Materials Research Part A DOI 10.1002/jbm.a
`
`

`

`DIFFERENTIATION OF MONONUCLEAR PRECURSORS INTO OSTEOCLASTS
`
`715
`
`Figure 8. Fluorescence microscopy image of the actin rings and vitronectin of multinucleated cells (osteoclasts), on the HA
`surface, after 21 days. (a) actin ring; (b) vitronectin; (c) colocalization of the vitronectin receptor within the cell and the surrounding
`actin ring; (d) nuclei, discontinuities (white arrow). [Color figure can be viewed in the online issue, which is available at
`www.interscience.wiley.com.]
`
`end of the culture period [Fig. 12(b)], but again it was
`not statistically significant.
`In the case of 1.5 wt % Si-HA, the release of phos-
`phate was significantly higher at day 15, when com-
`pared with the controls [Fig. 13(a)] (1.5 wt % Si-HA
`NC – 1.07 mmol/L, p ⬍ 0.014; 1.5 wt % Si-HA MCSF
`– 1.06 mmol/L, p ⬍ 0.011; and 1.5 wt % Si-HA OC –
`1.27 mmol/L). While a similar increase was observed
`at the same time point for calcium it did not reach
`statistical significance [Fig. 13(b)]. At day 21 the cal-
`cium and phosphate content in the 1.5 wt % Si-HA OC
`medium was significantly higher than the controls
`(calcium: 1.5 wt % Si-HA NC – 1.77 mmol/L, p ⬍
`0.001; 1.5 wt % Si-HA MCSF – 1.86 mmol/L, p ⬍ 0.001;
`and 1.5 wt % Si-HA OC – 2.58 mmol/L; phosphate, 1.5
`wt % Si-HA NC – 1.06 mmol/L, p ⬍ 0.001; 1.5 wt %
`Si-HA MCSF – 1.17 mmol/L, p ⬍ 0.001; 1.5 wt %
`Si-HA OC – 1.57 mmol/L). These results indicate that
`the osteoclasts are active and resorbing.
`
`Once again the calcium and phosphate concentra-
`tion in media from the experimental samples in-
`creased with the increase in silicon content. When
`comparing the three materials, the calcium and phos-
`phate content in the medium of 1.5 wt % Si-HA OC at
`day 21 was significantly higher than for HA OC and
`0.8 wt % Si-HA OC (calcium – HA OC, p ⬍ 0.001; 0.8
`wt % Si-HA OC, p ⬍ 0.001; phosphate – HA OC, p ⬍
`0.001; 0.8 wt % Si-HA OC, p ⬍ 0.015). No significant
`difference was detected when the results from HA and
`0.8 wt % Si-HA were compared.
`
`DISCUSSION
`
`Through this study, it was possible to demonstrate
`that HA and Si-HA allows the differentiation of PBMC
`and CD14⫹ selected mononuclear cells into mature
`(cid:26)(cid:3)(cid:82)(cid:73)(cid:3)(cid:20)(cid:21)
`
`Journal of Biomedical Materials Research Part A DOI 10.1002/jbm.a
`
`

`

`716
`
`BOTELHO ET AL.
`
`Figure 9. A detailed view of the osteoclasts on the surface of 0.8 wt % Si-HA (a, b, and c) and 1.5 wt % Si-HA (d, e, and f)
`after 21 days. (a)and (d) actin rings; (b) and (e) vitronectin; (c) and (f) nuclei.
`
`tronectin receptors. Although some of these markers
`osteoclasts. Most of the cells on the surface of the
`are expressed by other cell types such as macrophages,
`materials expressed osteoclastic markers: actin rings,
`according to Monchau et al., the formation of an actin
`multinuclearity, expressed TRAP, and presented vi-
`(cid:27)(cid:3)(cid:82)(cid:73)(cid:3)(cid:20)(cid:21)
`
`Journal of Biomedical Materials Research Part A DOI 10.1002/jbm.a
`
`

`

`DIFFERENTIATION OF MONONUCLEAR PRECURSORS INTO OSTEOCLASTS
`
`717
`
`Figure 10. Confocal laser scanning microscopy images of the actin rings surrounding vitronectin receptors within the
`multinucleated cells – osteoclasts, on the 0.8 wt % Si-HA (a, c) and 1.5 wt % Si-HA (b, d) surfaces, after 21 days. (a) and (b)
`actin rings; (c) (d) vitronectin (white arrow indicates podosomes). [Color figure can be viewed in the online issue, which is
`available at www.interscience.wiley.com.]
`
`ring is the best in vitro method to confirm the oste-
`through complex focal adhesion contacts containing
`oclastic phenotype.21 In the fluorescence images, it
`several proteins in a ring shape at the periphery of the
`cell.22,23 In the fluorescence images, it was possible to
`was possible to identify podosomes. It is through this
`observe this structure, the actin ring, in the experimen-
`structure that osteoclasts adhere to the surface, via an
`intramembranous integrin (␣
`␤
`tal samples. It is under this actin ring that the oste-
`3). These molecules act
`v
`oclast makes a tight contact with the surface, followed
`as an intermediate between the extracellular matrix
`by the secretion of protons and proteases, which will
`proteins and the intracellular cytoskeletal actin micro-
`dissolve the bone crystals or the ceramic samples, as
`filaments. The microfilaments bind to integrins
`(cid:28)(cid:3)(cid:82)(cid:73)(cid:3)(cid:20)(cid:21)
`
`Journal of Biomedical Materials Research Part A DOI 10.1002/jbm.a
`
`

`

`718
`
`BOTELHO ET AL.
`
`Figure 11. Phosphate (a) and calcium (b) concentration of
`the medium at different time points for the HA controls and
`the HA sample with osteoclasts (n ⫽ 3).
`
`Figure 13. Phosphate (a) and calcium (b) concentration in
`the medium at different time points for the 1.5 wt % Si-HA
`controls and the 1.5 wt % Si-HA sample with osteoclasts.
`(*Statistical difference p ⬍ 0.05, n ⫽ 3).
`
`in this in vitro study.22,23 The resorption products
`are endocytosed from the ruffled border and then
`transcytosed and released at the functional secretory
`domain in the top of
`the osteoclast basal mem-
`brane.24,25 Some of the actin rings presented disconti-
`
`nuity, which could be due to the change in the oste-
`oclast phase, resorption to migration or a decrease in
`the cellular activity.21 When the osteoclast is changing
`from the non-resorbing to the resorbing stage a large
`reorganization takes place, and, in the first stage of the
`resorption cycle, actin and vinculin are distributed
`throughout the podosomes. In the next stage, these
`structures coalesce to a specific area of the osteoclast,
`and the actin and vinculin stains dissociate. These
`changes are important because they reflect the cells’
`interaction with the extracellular environment.26
`To ensure that the calcium and phosphate measured
`in the medium was related to the osteoclastic activity
`and not related to either acellular degradation or non-
`osteoclast cell activity, several controls were per-
`formed. Each ceramic was simultaneously exposed to
`culture medium alone (without cells) and to cells but
`no cytokines (first experiment). In the second experi-
`ment, a different control was added; the samples were
`incubated with cells plus MCSF, to verify that resorp-
`tion occurs only in the presence of osteoclasts. In this
`second control, only MCSF was added and no
`RANKL, to avoid the differentiation of osteoclasts
`precursors into mature osteoclasts. Several studies
`have demonstrated the importance of RANKL for the
`differentiation and activation of osteoclast precursors.
`Figure 12. Phosphate (a) and calcium (b) concentration in
`It has been demonstrated that RANKL is fundamental
`the medium at different time points for the 0.8 wt % Si-HA
`for osteoclastogenesis and that this phenomenon can
`controls and the 0.8 wt % Si-HA samples with osteoclasts.
`(cid:20)(cid:19)(cid:3)(cid:82)(cid:73)(cid:3)(cid:20)(cid:21)
`Journal of Biomedical Materials Research Part A DOI 10.1002/jbm.a
`
`

`

`DIFFERENTIATION OF MONONUCLEAR PRECURSORS INTO OSTEOCLASTS
`
`719
`
`ceramic showed evidence of osteoclast resorption,
`while no evidence of cellular resorption was observed
`on the HA samples.12 Although Patel et al. did not
`reported the presence of osteoclast-like cells in vivo,13
`we were able to demonstrate that Si-HA material can
`be resorbed by cellular mechanisms and that silicon
`has a positive effect on osteoclast activity. Although
`the exact mechanism behind this is still unknown and
`further studies are required.
`The primary objective for synthetic bone substitute
`research is the development of an implantable mate-
`rial which combines initial rapid healing with the
`subsequent capability to be progressively resorbed by
`osteoclasts during normal continuous tissue remodel-
`ing.12 So, Si-HA seems to be a good candidate.
`
`inter-
`be affect by several factors, namely MCSF,
`lukin-1, transforming growth factor-␤, tumor necrosis
`factor-␣,
`interlukin-6, vitamin D3, and parathyroid
`hormone. Although all these cytokines are very im-
`portant, they cannot induce the differentiation of os-
`teoclast precursors alone.27–31 The ability of TNF-␣ to
`induce osteoclastogenesis is still controversial. It has
`been shown that TNF-␣ can induce osteoclastogenesis,
`but by the stimulation of osteoblast/stromal cells to
`produce RANKL,32 or, if this cytokine acts directly on
`osteoclast precursors, at
`least a small amount of
`RANKL must be present.32 RANKL has the ability to
`induce osteoclastogenesis in the presence of MCSF.28
`RANKL acts on osteoclast precursors through a mem-
`brane receptor, RANK (receptor activator of NF-␬␤)
`activating osteoclastogenesis, although if it binds to
`the decoy receptor osteoprotegerin osteoclastogenesis
`will be inhibited.28 It has been established that MCSF
`is involved in the proliferation and survival of oste-
`oclast progenitors and osteoclasts, but it does not stim-
`ulate their resorbing activity.7,33
`The analyses of culture medium from the experi-
`mental samples showed significant differences. 1.5 wt
`% Si-HA had higher concentrations of calcium and
`phosphate in the medium from the samples contain-
`ing osteoclasts when compared between the three ma-
`terials and the controls, with the exception of 1.5 wt %
`and 0.8 wt % Si-HA, using PBMC as a starting culture,
`which indicates that the osteoclasts were active and
`resorbing on 1.5 wt % Si-HA. Similar increases in
`calcium and phosphate in the medium were reported
`by Zhang et al., when he seeded mature osteoclasts on
`the surface of bioglass.34 In the case of 0.8 wt % Si-HA,
`a higher increase in phosphate was observed in both
`cultures. No significant difference was observed be-
`tween HA and 0.8 wt % Si-HA. The difference be-
`tween the results obtained in the two starting cultures,
`PBMC, and CD14⫹, could be due to the presence of a
`mixed population of cells in the case of PBMC, only a
`small fraction of which are CD14⫹.
`From these results, it seems that HA is likely to be
`less resorbable in vitro, although other studies have
`shown evidence of resorption on HA.35,36 Several fac-
`tors can influence osteoclastic resorption, such as sin-
`tering temperature, porosity, grain size, and experi-
`mental conditions.11,36
`It seems that there is an increased resorption from
`the Si-HA materials compared to HA. It is known that
`a stable collagenous matrix is important for osteoclast
`attachment, for the actin ring formation, and conse-
`quent resorption.32 It was previously demonstrated
`that Si-HA has a higher binding capacity to collagen
`and that its affinity increases with silicon content,
`which can lead to an increase in the osteoclast resorp-
`tion activity.37 Similar results were obtained by Lang-
`staff et al., where it was demonstrated that a silicon-
`stabilized calcium phosphate coating and bulk
`(cid:20)(cid:20)(cid:3)(cid:82)(cid:73)(cid:3)(cid:20)(cid:21)
`Journal of Biomedical Materials Research Part A DOI 10.1002/jbm.a
`
`1. Schilling A, Linhart W, Filke S, Gebauer M, Schinke T, Rueger
`J, Amling M. Resorbability of bone substitute biomaterials by
`human osteoclasts. Biomaterials 2004;25:3963–3972.
`2. Miller P, Baram D, Bilezkian J, Greenspan S, Lindsay R, Riggs
`B, Watts N. Practical clinical application of biochemical mark-
`ers of bone turnover: Consensus of an expert

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket